Logo image of XELA

EXELA TECHNOLOGIES INC (XELA) Stock Fundamental Analysis

USA - NASDAQ:XELA - US30162V8054 - Common Stock

1.15 USD
-0.83 (-41.92%)
Last: 11/7/2024, 8:12:48 PM
1.2 USD
+0.05 (+4.35%)
After Hours: 11/7/2024, 8:12:48 PM
Fundamental Rating

1

Taking everything into account, XELA scores 1 out of 10 in our fundamental rating. XELA was compared to 86 industry peers in the IT Services industry. XELA may be in some trouble as it scores bad on both profitability and health. XELA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

XELA had negative earnings in the past year.
XELA had a positive operating cash flow in the past year.
XELA had negative earnings in each of the past 5 years.
In the past 5 years XELA reported 4 times negative operating cash flow.
XELA Yearly Net Income VS EBIT VS OCF VS FCFXELA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100M -200M -300M -400M -500M

1.2 Ratios

Looking at the Return On Assets, with a value of -18.44%, XELA is doing worse than 79.76% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 0.64%, XELA is in line with its industry, outperforming 44.05% of the companies in the same industry.
Industry RankSector Rank
ROA -18.44%
ROE N/A
ROIC 0.64%
ROA(3y)-31.16%
ROA(5y)-29.95%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
XELA Yearly ROA, ROE, ROICXELA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500 1K 1.5K 2K

1.3 Margins

XELA has a Operating Margin (0.14%) which is comparable to the rest of the industry.
With a Gross Margin value of 22.23%, XELA is not doing good in the industry: 73.81% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of XELA has declined.
Industry RankSector Rank
OM 0.14%
PM (TTM) N/A
GM 22.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.37%
GM growth 5Y-1.6%
XELA Yearly Profit, Operating, Gross MarginsXELA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20

More info and screens

0

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so XELA is destroying value.
The number of shares outstanding for XELA has been increased compared to 1 year ago.
Compared to 5 years ago, XELA has more shares outstanding
The debt/assets ratio for XELA is higher compared to a year ago.
XELA Yearly Shares OutstandingXELA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
XELA Yearly Total Debt VS Total AssetsXELA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

XELA has an Altman-Z score of -3.85. This is a bad value and indicates that XELA is not financially healthy and even has some risk of bankruptcy.
XELA has a Altman-Z score of -3.85. This is amonst the worse of the industry: XELA underperforms 89.29% of its industry peers.
The Debt to FCF ratio of XELA is 45.59, which is on the high side as it means it would take XELA, 45.59 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 45.59, XELA is in line with its industry, outperforming 40.48% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 45.59
Altman-Z -3.85
ROIC/WACC0.08
WACC8.14%
XELA Yearly LT Debt VS Equity VS FCFXELA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M -500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 0.38 indicates that XELA may have some problems paying its short term obligations.
XELA has a Current ratio of 0.38. This is amonst the worse of the industry: XELA underperforms 95.24% of its industry peers.
A Quick Ratio of 0.35 indicates that XELA may have some problems paying its short term obligations.
XELA has a Quick ratio of 0.35. This is amonst the worse of the industry: XELA underperforms 95.24% of its industry peers.
Industry RankSector Rank
Current Ratio 0.38
Quick Ratio 0.35
XELA Yearly Current Assets VS Current LiabilitesXELA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 97.10% over the past year.
The Revenue has decreased by -5.15% in the past year.
XELA shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -7.67% yearly.
EPS 1Y (TTM)97.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.63%
Revenue 1Y (TTM)-5.15%
Revenue growth 3Y-6.28%
Revenue growth 5Y-7.67%
Sales Q2Q%-9.98%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-18.13%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.52%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
XELA Yearly Revenue VS EstimatesXELA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
XELA Yearly EPS VS EstimatesXELA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 -5K -10K -15K

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for XELA. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for XELA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XELA Price Earnings VS Forward Price EarningsXELA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of XELA indicates a somewhat cheap valuation: XELA is cheaper than 60.71% of the companies listed in the same industry.
98.81% of the companies in the same industry are more expensive than XELA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 0.31
EV/EBITDA 17.97
XELA Per share dataXELA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 100 -100

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

XELA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EXELA TECHNOLOGIES INC

NASDAQ:XELA (11/7/2024, 8:12:48 PM)

After market: 1.2 +0.05 (+4.35%)

1.15

-0.83 (-41.92%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)08-06 2024-08-06/amc
Earnings (Next)11-28 2024-11-28/amc
Inst Owners8.43%
Inst Owner Change0%
Ins Owners1296.91%
Ins Owner Change0%
Market Cap7.33M
Revenue(TTM)1.02B
Net Income(TTM)-108410000
Analysts43.33
Price Target2.04 (77.39%)
Short Float %N/A
Short Ratio1.38
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend3.37
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF 0.31
P/OCF 0.2
P/B N/A
P/tB N/A
EV/EBITDA 17.97
EPS(TTM)-17.03
EYN/A
EPS(NY)-1.16
Fwd EYN/A
FCF(TTM)3.73
FCFY324.44%
OCF(TTM)5.7
OCFY495.67%
SpS160.44
BVpS-141.88
TBVpS-191.92
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -18.44%
ROE N/A
ROCE 0.82%
ROIC 0.64%
ROICexc 0.78%
ROICexgc N/A
OM 0.14%
PM (TTM) N/A
GM 22.23%
FCFM 2.33%
ROA(3y)-31.16%
ROA(5y)-29.95%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.37%
GM growth 5Y-1.6%
F-Score6
Asset Turnover1.74
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 45.59
Debt/EBITDA 17.34
Cap/Depr 21.79%
Cap/Sales 1.23%
Interest Coverage 0.02
Cash Conversion 61.52%
Profit Quality N/A
Current Ratio 0.38
Quick Ratio 0.35
Altman-Z -3.85
F-Score6
WACC8.14%
ROIC/WACC0.08
Cap/Depr(3y)23.88%
Cap/Depr(5y)21.7%
Cap/Sales(3y)1.52%
Cap/Sales(5y)1.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)97.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.63%
EPS Next Y-18.13%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.15%
Revenue growth 3Y-6.28%
Revenue growth 5Y-7.67%
Sales Q2Q%-9.98%
Revenue Next Year5.52%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y105.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year295.42%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y137.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y192.16%
OCF growth 3YN/A
OCF growth 5Y-31.51%